Phillip Lai
Genentech · 28 works · 1,826 citations · h-index 7
Top works
- Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration
- Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
- Ranibizumab for Macular Edema Due to Retinal Vein Occlusions
- Intraocular Pressure in Eyes Receiving Monthly Ranibizumab in 2 Pivotal Age-Related Macular Degeneration Clinical Trials
- Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy
- Macular Sensitivity Endpoints in Geographic Atrophy
- Meta-analysis examining the systemic safety profile of intravitreal ranibizumab injections in AMD, RVO and DME
- A Common SNP at the CFI Locus is Associated with Rapid Progression of Geographic Atrophy
- Phase 1 Study of the Anti-HtrA1 Antibody-binding Fragment FHTR2163 in Geographic Atrophy Secondary to Age-related Macular Degeneration
- Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration
- HARBOR Study: One-Year Results of Efficacy and Safety of 2.0 mg versus 0.5 mg Ranibizumab in Patients with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
- Nonclinical Safety Assessment of FHTR2163, An Antigen-Binding Fragment Against HTRA1 for the Treatment of Geographic Atrophy
- Initial lesion growth rates and other baseline prognostic factors can improve the design of clinical trials in Geographic Atrophy (GA)
- Outer Retinal Tubulation as a Predictor of the Growth Rate of Geographic Atrophy in Age-related Macular Degeneration
- Rare CIDEC coding variants enriched in age-related macular degeneration patients with small low-luminance deficit cause lipid droplet and fat storage defects
- Correlation between Fundus Autofluorescence and Spectral Domain Optical Coherence Tomography Measurements in Geographic Atrophy
- Phase 1 safety study of intravitreal (ITV) Anti-High Temperature Requirement A1 (aHtrA1), a novel serine protease inhibitor, in patients with Geographic Atrophy (GA)
- Functional and Ultrastructural Assessment of Novel OCT Findings in the Cynomolgus Monkey
- Report of the 2023 Mary Tyler Moore Vision Initiative Workshop
- Age-related Macular Degeneration patient deep phenotyping and whole genome sequencing analysis identifies coding variants linking small low-luminance visual deficit to fat storage defects